Exclusive: One Dose Is Enough – The Surprise in Pfizer’s COVID Vaccine Data | Dave Lashmet

In a Stansberry Research exclusive, Dave Lashmet, Editor of Venture Technology shares a surprising revelation with Jessica Stone about Pfizer’s latest COVID vaccine data. The data Tuesday revealed that the end of COVID-19 is 12 months away with a one-dose vaccine. Dave dug through the data to discover that two doses of the vaccine cause double the side effects and takes twice the supply without any apparent advantages.